GenMont Biotech Incorporation (TPE:3164)
16.60
+0.20 (1.22%)
May 29, 2026, 1:30 PM CST
-18.83% (1Y)
| Market Cap | 1.43B -18.3% |
| Revenue (ttm) | 401.23M +6.1% |
| Net Income | 57.20M +15.2% |
| EPS | 0.66 +15.7% |
| Shares Out | 86.01M |
| PE Ratio | 25.15 |
| Forward PE | n/a |
| Dividend | 0.80 (4.82%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 253,989 |
| Open | 16.40 |
| Previous Close | 16.40 |
| Day's Range | 16.00 - 16.60 |
| 52-Week Range | 16.05 - 22.40 |
| Beta | 0.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 15, 2026 |